Kiribati

Reimbursed Care Access

Kiribati regulates controlled substances under domestic Dangerous Drugs legislation (Dangerous Drugs Ordinance 1948 and related amendments) administered via the Ministry of Health and Community Affairs; most classical psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca components, mescaline, 2C‑X) are treated as controlled/ prohibited substances with no routine medical or reimbursed access. Ketamine is used in clinical practice worldwide as an anaesthetic and is listed on the WHO Model List of Essential Medicines, and therefore may be available for authorized medical/anaesthetic use in Kiribati under standard medical supply/import controls, but there is no evidence of national reimbursement programs or specialized psychedelic‑therapy funding in Kiribati. National law references and import/control frameworks for dangerous drugs are the primary legal source for status and access. [https://kiribati.tradeportal.org/regulations/index|Kiribati Trade Portal - Regulations] [https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists|WHO Model List of Essential Medicines]